ArticleHeliyon2020
Microplastics in tropical Andean rivers: A perspective from a highly populated Ecuadorian basin without wastewater treatment.
Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Microplastics in Ecuador: A review of environmental and health-risk assessment challenges.Heliyon · 2024Review
- Beer Safety: New Challenges and Future Trends within Craft and Large-Scale Production.Foods (Basel, Switzerland) · 2022Review
- Selection of a density separation solution to study microplastics in tropical riverine sediment.Environmental monitoring and assessment · 2022Article
- Conservation threats and future prospects for the freshwater fishes of Ecuador: A hotspot of Neotropical fish diversity.Journal of fish biology · 2021Review
- COVID-19 pandemic repercussions on plastic and antiviral polymeric textile causing pollution on beaches and coasts of South America.The Science of the total environment · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the problem of microplastic pollution has begun to receive more attention. Currently, it is known that these particles, less than 5 mm in diameter, can lead to problems for both ecosystems and human health due to the toxicity of their components. In spite of this, research on this topic has focused mainly on the oceans, leaving aside rivers, which are the main source of these pollutants to oceans. Additionally, information is limited to certain rivers in countries of the northern hemisphere where wastewater treatment plants can retain up to 80% of microplastics. In South America, microplastic pollution is practically unknown, and wastewater treatment in several areas is still limited. This study focused on quantifying the microplastics present in the upper basin of the Guayllabamba River, in the Tropical Andes, a biodiversity hotspot. This basin is where the capital city of Ecuador, Quito, is located. Less than 10% of the wastewater in Quito is treated and the rest is dumped to rivers without treatment. We performed a physical analysis of microplastics, by weight and by category of microplastic, in various sampling points before and after urban areas. We found microplastic pollution beginning in the headwaters of the basin, with significant increases in urban areas of the Metropolitan District of Quito. Values of suspended microplastics in rivers after urban areas were higher than those recorded in the literature. Plastic levels in sediment were also higher after urban areas. Microplastics were highly correlated with other water pollutants, showing the prevailing necessity of wastewater treatment plants, because all of this pollution is dumped into rivers that flow from 2800 m a.s.l. to highly diverse freshwater ecosystems and human populations located downstream that depend on these aquatic sources, and finally to the Pacific Ocean.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.